Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Murakami

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 19, 2002
[Dynamics in neuronal migration and axonal expansion]Toshio Murakami
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|December 17, 2011
[Factors related to subjective fatigue symptoms of adolescent girls]Junko Ikeda, Sayuri Fukuda, Toshio Murakami, et al.
Plos One|March 6, 2025
A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cellsGo Okita, Kiyotaka Suenaga, Masashi Sakaguchi, et al.
AIDS (London, England)|January 29, 2015
Passive transfer of neutralizing mAb KD-247 reduces plasma viral load in patients chronically infected with HIV-1Shuzo Matsushita, Kazuhisa Yoshimura, Kristel Paola Ramirez, et al.
Journal of Virology|January 26, 2007
Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolateJunji Shibata, Kazuhisa Yoshimura, Akiko Honda, et al.
Journal of Bioscience and Bioengineering|November 13, 2008
Large-scale production of major house dust mite allergen der f 2 mutant (C8/119S) in Escherichia coliSatoshi Koyanagi, Toshihiro Maeda, Toshio Murakami, et al.
Biochemical and Biophysical Research Communications|May 15, 2016
Conformational properties of the third variable loop of HIV-1AD8 envelope glycoprotein in the liganded conditionsSatoshi Takeda, Mari Takizawa, Kosuke Miyauchi, et al.
Human Antibodies|May 25, 2006
Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247Shuzo Matsushita, Soichiro Takahama, Junji Shibata, et al.
Journal of Bioscience and Bioengineering|June 16, 2010
Production-scale purification of the recombinant major house dust mite allergen Der f 2 mutant C8/119SSatoshi Koyanagi, Toshio Murakami, Toshihiro Maeda, et al.
AIDS (London, England)|October 21, 2006
Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitorsKazuhisa Yoshimura, Junji Shibata, Tetsuya Kimura, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 19, 2002
[Dynamics in neuronal migration and axonal expansion]Toshio Murakami
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|December 17, 2011
[Factors related to subjective fatigue symptoms of adolescent girls]Junko Ikeda, Sayuri Fukuda, Toshio Murakami, et al.
Plos One|March 6, 2025
A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cellsGo Okita, Kiyotaka Suenaga, Masashi Sakaguchi, et al.
AIDS (London, England)|January 29, 2015
Passive transfer of neutralizing mAb KD-247 reduces plasma viral load in patients chronically infected with HIV-1Shuzo Matsushita, Kazuhisa Yoshimura, Kristel Paola Ramirez, et al.
Journal of Virology|January 26, 2007
Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolateJunji Shibata, Kazuhisa Yoshimura, Akiko Honda, et al.
Journal of Bioscience and Bioengineering|November 13, 2008
Large-scale production of major house dust mite allergen der f 2 mutant (C8/119S) in Escherichia coliSatoshi Koyanagi, Toshihiro Maeda, Toshio Murakami, et al.
Biochemical and Biophysical Research Communications|May 15, 2016
Conformational properties of the third variable loop of HIV-1AD8 envelope glycoprotein in the liganded conditionsSatoshi Takeda, Mari Takizawa, Kosuke Miyauchi, et al.
Human Antibodies|May 25, 2006
Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247Shuzo Matsushita, Soichiro Takahama, Junji Shibata, et al.
Journal of Bioscience and Bioengineering|June 16, 2010
Production-scale purification of the recombinant major house dust mite allergen Der f 2 mutant C8/119SSatoshi Koyanagi, Toshio Murakami, Toshihiro Maeda, et al.
AIDS (London, England)|October 21, 2006
Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitorsKazuhisa Yoshimura, Junji Shibata, Tetsuya Kimura, et al.
Pageof 2